 NEW HAVEN, Conn., Oct. 27, 2021 GLOBE NEWSWIRE -- BioXcel Therapeutics, Inc. Nasdaq: BTAI, a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that it will release its third quarter 2021 financial results on Wednesday, November 10, 2021 before the open of the U.S. financial markets. BioXcel Therapeutics management team will also host a conference call and webcast at 8:30 AM ET to discuss the Companys financial results and to provide a general business update. 